Screener
GNOM vs GXLC
Global X Genomics & Biotechnology ETF vs Global X U.S. 500 ETF
Side-by-side comparison
| GNOM | GXLC | |
|---|---|---|
| Annual cost (TER) | 0.50% | — |
| Fund size (AUM) | $51M | — |
| Since | 2019 | — |
| Dividend yield | 1.38% | — |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +53.6% | N/A |
| CAGR 3Y | -2.6% | N/A |
| CAGR 5Y | -10.5% | N/A |
| Sharpe 3Y | -0.06 | N/A |
| Volatility 1Y | 26.15% | — |
| Max drawdown | -75.00% | -9.08% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to GNOM and GXLC
Explore further